Sweeping Changes At CDER Recommended In IoM Drug Safety Report
This article was originally published in The Pink Sheet Daily
Executive Summary
Among solutions suggested is six-year fixed term for the FDA commissioner and appointment of external advisory board to oversee cultural changes.